Table 1.
Characteristics of Health Plan Members Aged 12–64 years Receiving COVID-19 Vaccines Overall and Stratified by Vaccine Brand in the Optum, HealthCore, and CVS Health Databases.
| Patient Characteristicsa |
Optum (data through 1/22/2022) |
HealthCore (data through 1/7/2022) |
CVS Health (data through 12/31/2022) |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | mRNA-1273 | BNT162b2 | Ad26.COV2.S | Multiple | Total | mRNA-1273 | BNT162b2 | Ad26.COV2.S | Multiple | Total | mRNA-1273 | BNT162b2 | Ad26.COV2.S | Multiple | |
| N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | N/% | |
| Total | 5,070,372 | 1,558,811 | 3,100,326 | 220,434 | 190,801 | 7,445,051 | 2,429,049 | 4,386,627 | 376,968 | 252,407 | 4,326,594 | 1,373,442 | 2,631,526 | 186,743 | 134,883 |
| Age at First Dose (Years) | |||||||||||||||
| 12–17 | 8.5% | 0.0% | 13.9% | 0.0% | 1.0% | 8.5% | 0.1% | 14.3% | 0.0% | 1.2% | 8.1% | 0.2% | 13.1% | 0.0% | 1.8% |
| 18–25 | 11.6% | 11.7% | 11.4% | 13.8% | 11.9% | 12.9% | 12.7% | 13.0% | 14.9% | 10.2% | 12.9% | 13.0% | 12.7% | 15.7% | 11.8% |
| 26–35 | 19.0% | 20.1% | 18.5% | 18.9% | 19.6% | 17.2% | 17.9% | 16.9% | 16.4% | 17.8% | 19.7% | 20.5% | 19.3% | 18.7% | 20.3% |
| 36–45 | 20.7% | 22.2% | 19.7% | 21.7% | 24.0% | 19.2% | 20.5% | 18.3% | 19.8% | 22.5% | 19.6% | 20.7% | 18.8% | 20.3% | 23.0% |
| 46–55 | 21.1% | 23.4% | 19.6% | 24.6% | 23.9% | 21.0% | 23.4% | 19.1% | 25.0% | 24.4% | 19.9% | 21.9% | 18.5% | 23.1% | 22.3% |
| 56–64 | 19.0% | 22.5% | 17.0% | 21.0% | 19.6% | 21.1% | 25.4% | 18.4% | 23.8% | 23.9% | 19.8% | 23.7% | 17.6% | 22.1% | 20.7% |
| Sex | |||||||||||||||
| Female | 52.3% | 52.4% | 52.9% | 43.7% | 51.0% | 52.6% | 53.2% | 53.1% | 44.4% | 50.9% | 52.8% | 52.9% | 53.4% | 44.5% | 50.7% |
| Male | 47.7% | 47.6% | 47.1% | 56.3% | 49.0% | 47.4% | 46.8% | 46.9% | 55.6% | 49.1% | 47.2% | 47.1% | 46.6% | 55.5% | 49.2% |
| Urban/Rural | |||||||||||||||
| Rural | 5.4% | 7.9% | 4.1% | 8.5% | 4.0% | 11.6% | 16.2% | 8.7% | 16.3% | 8.8% | 4.5% | 6.3% | 3.3% | 7.3% | 3.7% |
| Urban | 94.4% | 91.9% | 95.8% | 91.4% | 95.9% | 88.4% | 83.8% | 91.2% | 83.7% | 91.2% | 95.1% | 93.3% | 96.2% | 92.1% | 96.2% |
| HHS Region | |||||||||||||||
| Region 1 | 5.0% | 5.2% | 4.8% | 4.9% | 6.9% | 7.2% | 7.4% | 7.0% | 7.6% | 8.6% | 5.7% | 5.7% | 5.6% | 6.0% | 8.8% |
| Region 2 | 7.5% | 7.4% | 7.6% | 6.4% | 6.2% | 7.2% | 7.6% | 7.0% | 6.2% | 6.3% | 16.9% | 17.6% | 16.8% | 14.5% | 16.1% |
| Region 3 | 7.9% | 8.5% | 7.5% | 8.1% | 8.7% | 9.0% | 9.8% | 8.8% | 8.0% | 6.1% | 13.4% | 14.1% | 13.0% | 12.6% | 12.8% |
| Region 4 | 19.6% | 20.5% | 19.1% | 21.4% | 17.2% | 18.2% | 19.8% | 17.7% | 17.9% | 11.5% | 14.6% | 14.4% | 14.9% | 16.1% | 9.9% |
| Region 5 | 18.6% | 17.4% | 19.0% | 20.7% | 20.4% | 20.0% | 17.8% | 21.0% | 22.4% | 21.1% | 15.3% | 14.1% | 15.3% | 17.7% | 23.0% |
| Region 6 | 13.9% | 14.7% | 13.7% | 13.8% | 11.5% | 4.4% | 4.3% | 4.6% | 4.2% | 3.1% | 9.9% | 10.2% | 9.8% | 10.7% | 6.9% |
| Region 7 | 6.5% | 5.6% | 7.0% | 5.5% | 6.1% | 3.6% | 3.4% | 3.8% | 3.3% | 3.0% | 3.3% | 2.9% | 3.5% | 3.1% | 2.6% |
| Region 8 | 5.1% | 5.0% | 5.2% | 4.9% | 5.4% | 4.6% | 4.4% | 4.6% | 4.5% | 7.6% | 2.8% | 2.7% | 2.8% | 2.8% | 2.6% |
| Region 9 | 12.5% | 12.6% | 12.6% | 10.7% | 13.6% | 24.3% | 24.1% | 24.0% | 24.6% | 31.4% | 14.2% | 14.2% | 14.3% | 12.0% | 14.1% |
| Region 10 | 3.3% | 2.9% | 3.4% | 3.5% | 3.9% | 1.5% | 1.3% | 1.5% | 1.5% | 1.2% | 3.6% | 3.8% | 3.6% | 4.0% | 3.1% |
Abbreviations: COVID-19, coronavirus disease of 2019; HHS, United States Department of Health and Human Services.
a Characteristics of the population were assessed at the time of first vaccine dose.
b Beneficiaries who receive >1 brand of COVID-19 vaccination are classified as “multiple.”
Missing/Unknown rows not shown.